Instem Helping to Educate the Quality Assurance Community on SEND
Instem to co-present at Research Quality Association’s North American Regional Forum
CONSHOHOCKEN, PA – March 17, 2017 - - Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce they will be co-presenting on CDISC’s Standard for Exchange of Nonclinical Data (SEND) at the Research Quality Association’s (RQA) North American Regional Forum.
Taking place Tuesday, March 21st at GlaxoSmithKline in Mississauga, Ontario, attendees to the session will learn about:
- An introductory overview of SEND
- Considerations when preparing for SEND, including how and where Quality Assurance should be involved
- Challenges that organizations go through when they are starting with SEND, both from a data perspective as well as a process perspective
- The importance for sponsors to perform a SEND review even if their SEND conversions are being handled by a CRO
- Specific examples of what QA departments are doing to successfully implement SEND
“I am thrilled to co-present this session on the impact of SEND on the QA community. This forum is the perfect environment to continue Instem’s commitment to educate and prepare CROs and Sponsors for SEND,” said Donna Danduone, Senior Director, Outsourcing Services at Instem.
For more information on this session, or Instem’s submit™ platform, the most widely adopted SEND software and outsourced study services in 15 countries, email email@example.com.
About the Research Quality Association
The RQA is an association dedicated to providing status and visibility for those concerned with the quality of research and development within the pharmaceutical, agrochemical, chemical and medical devices industries.
Since its inception in 1977, the RQA has grown and developed to reflect regulatory changes, the impact of regulatory inspection and the changing structure and needs of industry. For more information on the RQA, visit www.therqa.com.
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions and consulting services increases client productivity by enhancing product development processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
Beth Concordia (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600